LMP Capital and Income Fund Inc (SCD) Stock Price

16.01 ▲ +0.44 (+2.83%)
Open: 15.47 Vol: 170.4K Day's range: 15.46 - 16.01 Jun 13, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
SCD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL BUY SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 15.97▼ 15.96▲ 15.91▲ 16.30▼ 16.02▼
MA10 15.97▼ 15.84▲ 15.78▲ 16.41▼ 15.47▲
MA20 15.95▲ 15.81▲ 16.10▼ 16.12▼ 15.90▲
MA50 15.89▲ 16.33▼ 16.34▼ 15.40▲ 16.42▼
MA100 16.28▼ 18.97▼ 18.45▼ 16.03▼ 15.12▲
MA200 17.80▼ 16.95▼ 16.85▼ 16.58▼ 14.16▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.004▲ 0.064▲ 0.042▲ -0.057▼ 0.104▲
RSI 54.593▲ 47.029▼ 46.408▼ 50.212▲ 49.971▼
STOCH 56.349     97.549▲ 76.276     57.413     80.699▲
WILL %R -28.571     -4.706▲ -59.296     -61.538     -24.859▲
CCI -50.000     93.500     59.940     -72.494     79.359    
Latest Filters Detected On SCD
RSI $SCD RSI(14) Crossed Above 50 Set Alert
MA $SCD Price Crossed Above MA(26) Set Alert
CDL $SCD Engulfing Candlestick Pattern Detected Set Alert
CDL $SCD Marubozu Candlestick Pattern Detected Set Alert
LMP Capital and Income Fund Inc News
Beam Therapeutics Announces New Data From BEACON Phase 1/2 Clinical Trial Of BEAM-101 Supporting Differentiated Profile In Sickle Cell Disease (SCD) At European Hematology ...
Friday, June 13, 2025 04:37 AM
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of ...
Beam Therapeutics Reports Positive Updated Data from BEACON Trial of BEAM-101 for Sickle Cell Disease
Friday, June 13, 2025 04:11 AM
SCD is the most common inherited blood disorder ... About Beam Therapeutics Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated ...
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology ...
Friday, June 13, 2025 04:00 AM
SCD is the most common inherited blood disorder ... and approximately eight million people worldwide. Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the ...
SCD historical stock data
date open high low close volume
13/06/25 15.47 16.01 15.46 16.01 170,400
12/06/25 15.93 15.95 15.56 15.57 202,942
11/06/25 16.74 16.84 16.48 16.485 157,883
10/06/25 16.65 16.80 16.65 16.80 31,749
09/06/25 16.67 16.80 16.61 16.63 38,359
06/06/25 16.89 16.89 16.27 16.57 145,600
05/06/25 16.76 16.83 16.61 16.83 59,714
04/06/25 16.43 16.79 16.43 16.76 70,800
03/06/25 16.04 16.43 15.95 16.38 148,598
02/06/25 16.07 16.09 15.80 16.04 183,608
Quote Details
52wk Low:13.35
52wk High:17.96
Vol:170.4K
Avg Vol(3m):993.9K
1Y Chng:+3.83%
1M Chng:+4.30%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 248.40M